Lundbeck
HLUN-B.CO
#2877
Rank
S$7.41 B
Marketcap
S$7.81
Share price
-9.04%
Change (1 day)
-2.47%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2025 (TTM): S$0.80

According to Lundbeck's latest financial reports the company's current EPS (TTM) is S$0.78. In 2024 the company made an earnings per share (EPS) of S$0.56 an increase over its 2023 EPS that were of S$0.44.

EPS history for Lundbeck from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$0.8041.27%
2024S$0.5629.29%
2023S$0.4423.09%
2022S$0.3537.26%
2021S$0.26-84.61%
2020S$1.68-24.61%
2019S$2.22-42.06%
2018S$3.8440.7%
2017S$2.73146.26%
2016S$1.11-120.48%
2015S-$5.403231.32%
2014S-$0.16-115.78%
2013S$1.03-23.36%
2012S$1.34-48.01%
2011S$2.58-9.68%
2010S$2.8613.72%
2009S$2.5124.32%
2008S$2.02-6.05%
2007S$2.1581.77%
2006S$1.18-16.76%
2005S$1.42-17.58%
2004S$1.72